Reed Jobs

Reed Jobs, founder of Yosemite and son of Steve Jobs, shares his deep commitment to making cancer non-lethal, a mission influenced by his father's battle with the disease. He discusses innovative investment strategies in cancer treatment, emphasizing collaboration between philanthropy and biotechnology. Reed highlights the potential of AI, mRNA, and CRISPR in revolutionizing patient care and the critical need for early detection. His personal journey underscores the emotional stakes driving his work in advancing cancer research and the urgent realities faced today.

Reed Jobs, an investor leading Yosemite, is driven by a personal mission to make cancer non-lethal after losing his father to the disease. Joined by Matt Bettonville, they discuss the need for affordable cancer drugs and the surprising effectiveness of digital health tools in improving survival rates. They explore the potential of synthetic control arms to reduce clinical trial costs and emphasize the critical importance of early detection. Reed and Matt also highlight the urgency of maintaining U.S. leadership in global healthcare innovation.